The homeostatic model assessment (HOMA) [20] used to quantify insulin resistance and beta-cell function indicates that the treatment has produced a reduction of the beta-cell function (HOMA2- % β), which was no longer required to secrete a greater amount of insulin since insulin sensitivity was increased, as shown by a higher Cederholm Index (CI) [22]. Here, INS is linked to Insulin resistance.